Opioid maker Purdue’s bankruptcy case comes before Supreme Court
SCOTUSBlog
DECEMBER 2, 2023
The company conducted an aggressive marketing campaign for the drug, selling it as a relief option for a broad array of pain, from cancer to long-lasting sports injuries, and generating some $35 billion in revenue. The second question before the court centers on the legality of the plan itself.
Let's personalize your content